BCR-ABL tyrosine kinase fusion gene arises due to an acquired (9;22) genetic translocation that causes chronic myelogenous leukemia and BCR-ABL is associated with proliferation of tumor cells and induces disease progression [32]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.